2013 parkinson's disease glutathione 4 authors journal and neurodegenerative diseases: immunopharmacological implications Frontiers | Chemically Induced Models
Description
a method for raising circulating levels of glutathione to achieve clinically beneficial effects includes orally administering one or more doses of delayed-release S-acetyl-glutathione to an individual in need thereof
Selenium: Required cofactor for glutathione peroxidase, the enzyme family that uses glutathione to neutralize peroxides
doi: 10.1021/jf401545z
Your healthcare provider will recommend the most appropriate treatment based on your individual circumstances
doi: 10.3748/wjg.v11.i21.3222 133 LeeKHChoiEYKimMKKimKOJangBIKimSWet al
